, FACT Join Forces to Combat AF

The organization announced recently that it has decided to join forces with the Fair Access to Cardiac Technology (FACT) Alliance. The FACT Alliance is made up of various different patient advocacy groups and medical associations whose main goal is help patients suffering from atrial fibrillation receive fair access to heart healthcare technology and other services.

The FACT Alliance is seeking to raise AF awareness as well as help to bring its Mobile Cardiac Telemetry (MCT) unit into the mainstream. The MCT is a device that helps doctors diagnose AF and other heart problems early, which can lessen the patients’ chances of suffering from a stroke. Strokes are common among AF patients as blood clots often develop. is an online resource containing information that is related to atrial fibrillation. The website posts the latest medical news and events revolving around AF as well as treatment options and tips on maintenance of the condition. Both FACT and hope to eventually find a cure for the condition, but until that time comes, raising awareness and keeping the public and medical professionals on top of the latest news and research on AF will have to do.

Atrial fibrillation is a condition that is caused by patients suffering from irregular heartbeats and flutters. The condition is often treated with anticoagulant medications (blood thinners designed to help prevent strokes) including Multaq. Multaq is manufactured by Sanofi-Aventis and has been linked to serious conditions including liver failure and a worsening of the heart condition. Most recently, the drug has been linked to lung disease and pulmonary toxicity, as well.

If you or a family member has been diagnosed with liver failure, lung disease, pulmonary toxicity or a worsening of your heart condition after taking Multaq, contact attorney Greg Jones for a free consultation today. I am experienced at fighting Multaq lawsuits and may be able to get you money for your injuries.